1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SMARCE1 CTRPv2 pan-cancer AAC 0.16 4e-07
mRNA ARID1A CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA C7orf55-LUC7L2 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA ZNF737 CTRPv2 pan-cancer AAC 0.17 4e-07
mRNA ZNF232 CTRPv2 pan-cancer AAC 0.16 4e-07
mRNA TBC1D28 CTRPv2 pan-cancer AAC 0.16 4e-07
mRNA POLD1 CTRPv2 pan-cancer AAC 0.2 5e-07
mRNA TSPYL4 CTRPv2 pan-cancer AAC 0.17 5e-07
mRNA GATAD2B CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA TMED3 CTRPv2 pan-cancer AAC -0.17 5e-07
Download CSV